Glaucoma Drug Co. Says Investor Suit 'Makes No Sense'
Aerie Pharmaceuticals Inc. on Monday fired back at a putative class action brought by investors who say the company misled them into thinking its top drug would perform better in clinical...To view the full article, register now.
Already a subscriber? Click here to view full article